07:38 AM EDT, 08/18/2025 (MT Newswires) -- Propanc Biopharma ( PPCB ) shares were more than 151% higher pre-bell Monday, reversing from a 28% drop in the previous session.

BioXcel Therapeutics ( BTAI ) stock was up 29% after the company said it received positive comments from the US Food and Drug Administration regarding the company's planned supplemental new drug application submission for BXCL501 in agitation associated with bipolar disorders or schizophrenia.

Dayforce ( DAY ) shares were 26% higher following a media report that the company is being considered for takeover by Thoma Bravo.

Xunlei ( XNET ) stock was up 17%, extending Friday's rally.